| |
|
|
|
|
|
The 800 Series Laser is only available as a refurbished unit on a limited basis
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
The Ophthalmic Argon is used for the treatment of Retinal Tears, Macular Degeneration, Diabetic Retinopathy, Glaucoma, and Retinal Vein Occlusion.
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
Not only was Erchonia the first Low Level Laser to receive 510(k) market clearance from the FDA for Chronic Pain, Laser Assisted Liposuction, and now the treatment of Acne. Erchonia is now offering all three lasers in one conveinient unit
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
The Ceralas® Laser system, manufactured by biolitec, is used for the treatment of superficial reflux of the greater saphenous vein.
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
Call a Light Age solid state laser professional today to discuss your application and custom laser needs
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
The Erchonia DermaLaser™ is the FIRST and ONLY Low Level Laser (3LT) to be given FDA market clearance for the treatment of acne
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
80 Watts Holmium/100 Watts Nd:YAG
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
Erchonia's patented line of 3LT™ Lasers now includes the FIRST and ONLY Low Level Laser (3LT) to be given FDA market clearance for use during liposuction - the Erchonia Niera 4L™ Laser
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
The Fraxel re:fine™ laser system, introduced in 2007, offers patients – and physicians – an additional choice in non-invasive skin rejuvenation. Combining a more superficially absorbed laser wavelength with Fraxel’s unique fractional delivery, the Fraxel re:fine treatment offers a gentle yet effective option for improving skin texture, tone, pigmentation and fine lines – all with minimal patient downtime or discomfort.
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|
|
|
|
|
The Fraxel re:pair™ laser system delivers a new type of treatment called Fractional Deep Dermal Ablation (FDDA™) treatment. We expect to launch the Fraxel re:pair™ in the first quarter of 2008
|
Company:
Date:
July 22, 2008
|
|
|
|
|
|